JP2024062998A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024062998A5 JP2024062998A5 JP2024015762A JP2024015762A JP2024062998A5 JP 2024062998 A5 JP2024062998 A5 JP 2024062998A5 JP 2024015762 A JP2024015762 A JP 2024015762A JP 2024015762 A JP2024015762 A JP 2024015762A JP 2024062998 A5 JP2024062998 A5 JP 2024062998A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pya
- dap
- linked
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1805492.4 | 2018-04-04 | ||
| GBGB1805492.4A GB201805492D0 (en) | 2018-04-04 | 2018-04-04 | Heterotandem Bicyclic peptide complexes |
| GB1820981.7 | 2018-12-21 | ||
| GBGB1820981.7A GB201820981D0 (en) | 2018-12-21 | 2018-12-21 | Heterotandem bicyclic peptide complexes |
| PCT/GB2019/050951 WO2019193328A1 (en) | 2018-04-04 | 2019-04-02 | Heterotandem bicyclic peptide complexes |
| JP2020554265A JP7551500B2 (ja) | 2018-04-04 | 2019-04-02 | ヘテロタンデム二環式ペプチド複合体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554265A Division JP7551500B2 (ja) | 2018-04-04 | 2019-04-02 | ヘテロタンデム二環式ペプチド複合体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024062998A JP2024062998A (ja) | 2024-05-10 |
| JP2024062998A5 true JP2024062998A5 (enExample) | 2025-06-17 |
Family
ID=66175434
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554265A Active JP7551500B2 (ja) | 2018-04-04 | 2019-04-02 | ヘテロタンデム二環式ペプチド複合体 |
| JP2024015762A Pending JP2024062998A (ja) | 2018-04-04 | 2024-02-05 | ヘテロタンデム二環式ペプチド複合体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554265A Active JP7551500B2 (ja) | 2018-04-04 | 2019-04-02 | ヘテロタンデム二環式ペプチド複合体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11453703B2 (enExample) |
| EP (1) | EP3774851A1 (enExample) |
| JP (2) | JP7551500B2 (enExample) |
| KR (1) | KR20200139236A (enExample) |
| CN (1) | CN112236442A (enExample) |
| AU (2) | AU2019247795B2 (enExample) |
| BR (1) | BR112020020349A2 (enExample) |
| CA (1) | CA3095582A1 (enExample) |
| IL (1) | IL277717A (enExample) |
| MX (1) | MX2020010444A (enExample) |
| SG (1) | SG11202009773VA (enExample) |
| WO (1) | WO2019193328A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10532106B2 (en) | 2014-10-29 | 2020-01-14 | Bicyclerd Limited | Bicyclic peptide ligands specific for MT1-MMP |
| GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| JP2020502238A (ja) | 2016-12-23 | 2020-01-23 | バイスクルアールディー・リミテッド | 新規連結構造を有するペプチド誘導体 |
| WO2019002842A1 (en) | 2017-06-26 | 2019-01-03 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF |
| CN111183147B (zh) | 2017-08-04 | 2024-07-05 | 拜斯科技术开发有限公司 | Cd137特异性的双环肽配体 |
| TWI825046B (zh) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| JP2021514953A (ja) | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| KR20200139236A (ko) * | 2018-04-04 | 2020-12-11 | 바이사이클티엑스 리미티드 | 헤테로탠덤 비사이클릭 펩티드 복합체 |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| WO2020128526A1 (en) * | 2018-12-21 | 2020-06-25 | Bicycletx Limited | Bicyclic peptide ligands specific for pd-l1 |
| CN113260420A (zh) * | 2018-12-21 | 2021-08-13 | 拜斯科阿迪有限公司 | Pd-l1特异性的双环肽配体 |
| CN113811541A (zh) | 2019-05-09 | 2021-12-17 | 拜斯科技术开发有限公司 | Ox40特异性的双环肽配体 |
| TWI862640B (zh) | 2019-07-30 | 2024-11-21 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| JP2022544246A (ja) * | 2019-08-13 | 2022-10-17 | バイスクルテクス・リミテッド | 修飾された多量体二環式ペプチドリガンド |
| PL4464721T3 (pl) * | 2019-10-03 | 2025-08-25 | Bicycletx Limited | Heterotandemowe kompleksy peptydów bicyklicznych |
| GB201914872D0 (en) * | 2019-10-15 | 2019-11-27 | Bicycletx Ltd | Bicyclic peptide ligand drug conjugates |
| KR20230074721A (ko) | 2020-08-17 | 2023-05-31 | 바이사이클티엑스 리미티드 | Nectin-4에 특이적인 이환 콘쥬게이트 및 이의 용도 |
| GB202016331D0 (en) * | 2020-10-15 | 2020-12-02 | Bicyclerd Ltd | Bicyclic peptide ligand drug conjugates |
| US20240197897A1 (en) * | 2021-01-08 | 2024-06-20 | Bicycle TX Limited | Heterotandem bicyclic peptide complexes |
| US20250186539A2 (en) * | 2021-01-11 | 2025-06-12 | Bicycletx Limited | Methods for treating cancer |
| WO2022253051A1 (zh) * | 2021-06-01 | 2022-12-08 | 南京明德新药研发有限公司 | 多肽偶联药物及其应用 |
| US20250121076A1 (en) * | 2021-08-17 | 2025-04-17 | Medshine Discovery Inc. | Polypeptide drug conjugate having novel structure and application thereof |
| TWI803993B (zh) * | 2021-09-28 | 2023-06-01 | 廖嘉鴻 | 環胜肽自組裝3d微粒裝置及其製造方法 |
| AU2022356942B2 (en) * | 2021-09-29 | 2025-07-03 | Conjustar (Zhuhai) Biologics Co., Ltd. | Tricyclic polypeptide conjugated drug and use thereof |
| CN115819618B (zh) * | 2022-09-16 | 2023-10-27 | 哈尔滨工业大学 | 一种光激活的纳抗偶联物二聚化诱导剂pancid及其应用 |
| WO2025248261A1 (en) | 2024-05-31 | 2025-12-04 | Bicycletx Limited | Method for identifying patients |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| SI1844337T1 (sl) | 2005-01-24 | 2013-11-29 | Pepscan Systems B.V. | Povezovalne spojine, imunogene spojine in peptidomimetiki |
| US8680022B2 (en) | 2008-02-05 | 2014-03-25 | Bicycle Therapeutics Limited | Methods and compositions |
| GB0913775D0 (en) * | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
| CA2777242A1 (en) * | 2009-10-14 | 2011-04-21 | Merrimack Pharmaceuticals, Inc. | Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| JP2013518807A (ja) * | 2010-02-04 | 2013-05-23 | メディカル リサーチ カウンシル | 多重特異性ペプチド |
| PL2764140T3 (pl) * | 2011-10-07 | 2018-04-30 | Bicyclerd Limited | Modulacja specyficzności polipeptydów ustrukturyzowanych |
| US20140274759A1 (en) * | 2013-03-15 | 2014-09-18 | Bicycle Therapeutics Limited | Modification of polypeptides |
| US20170165334A1 (en) * | 2015-12-11 | 2017-06-15 | Tianxin Wang | Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification |
| US10532106B2 (en) | 2014-10-29 | 2020-01-14 | Bicyclerd Limited | Bicyclic peptide ligands specific for MT1-MMP |
| MA45328A (fr) | 2016-04-01 | 2019-02-06 | Avidity Biosciences Llc | Compositions acide nucléique-polypeptide et utilisations de celles-ci |
| KR102426765B1 (ko) * | 2016-04-22 | 2022-07-29 | 엘리게이터 바이오사이언스 에이비 | Cd137에 대한 신규한 이중특이성 폴리펩타이드 |
| CN111183147B (zh) | 2017-08-04 | 2024-07-05 | 拜斯科技术开发有限公司 | Cd137特异性的双环肽配体 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| TWI825046B (zh) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
| JP2021514953A (ja) | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| KR20200139236A (ko) * | 2018-04-04 | 2020-12-11 | 바이사이클티엑스 리미티드 | 헤테로탠덤 비사이클릭 펩티드 복합체 |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US11180531B2 (en) * | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| JP2022528887A (ja) | 2019-04-02 | 2022-06-16 | バイスクルテクス・リミテッド | バイシクルトキシンコンジュゲートおよびその使用 |
| TWI862640B (zh) | 2019-07-30 | 2024-11-21 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| PL4464721T3 (pl) | 2019-10-03 | 2025-08-25 | Bicycletx Limited | Heterotandemowe kompleksy peptydów bicyklicznych |
| IL293200A (en) | 2019-11-27 | 2022-07-01 | Bicycletx Ltd | Bicyclic peptide ligands specific for epha2 and uses thereof |
-
2019
- 2019-04-02 KR KR1020207031802A patent/KR20200139236A/ko not_active Ceased
- 2019-04-02 EP EP19717554.0A patent/EP3774851A1/en active Pending
- 2019-04-02 MX MX2020010444A patent/MX2020010444A/es unknown
- 2019-04-02 WO PCT/GB2019/050951 patent/WO2019193328A1/en not_active Ceased
- 2019-04-02 AU AU2019247795A patent/AU2019247795B2/en active Active
- 2019-04-02 US US16/372,692 patent/US11453703B2/en active Active
- 2019-04-02 SG SG11202009773VA patent/SG11202009773VA/en unknown
- 2019-04-02 BR BR112020020349-1A patent/BR112020020349A2/pt unknown
- 2019-04-02 CA CA3095582A patent/CA3095582A1/en active Pending
- 2019-04-02 CN CN201980037963.XA patent/CN112236442A/zh active Pending
- 2019-04-02 JP JP2020554265A patent/JP7551500B2/ja active Active
-
2020
- 2020-10-01 IL IL277717A patent/IL277717A/en unknown
-
2022
- 2022-05-12 US US17/663,169 patent/US20230008076A1/en active Pending
-
2024
- 2024-02-05 JP JP2024015762A patent/JP2024062998A/ja active Pending
- 2024-07-25 AU AU2024205105A patent/AU2024205105A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024062998A5 (enExample) | ||
| AU2013312689B2 (en) | Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof | |
| CA3017926C (en) | Methods for synthesizing .alpha.4.beta.7 peptide antagonists | |
| HRP20250081T1 (hr) | Biciklični peptidni ligandi specifični za nektin-4 | |
| KR101413051B1 (ko) | 뉴로펩타이드 ｙ 수용체 결합성 화합물을 포함하는 세포독성 접합체 | |
| CN119192401A (zh) | 异串联双环肽复合物 | |
| US9907838B2 (en) | Composition and methods for treating ischemic damage | |
| ES2332590T3 (es) | Dimero peptidico. | |
| ES2406090T3 (es) | Péptidos que tienen actividad farmacológica para tratar los trastornos asociados con la alteración de la migración celular, tal como el cáncer | |
| JP2017535527A5 (enExample) | ||
| CN112236442A (zh) | 异源串联双环肽复合物 | |
| JPH05508860A (ja) | 細胞接着制御環状化合物 | |
| JP2017522362A5 (enExample) | ||
| CA2309205A1 (en) | Novel conjugates of rgd-containing peptides and endogenous carriers | |
| JPWO2021019243A5 (enExample) | ||
| Bose et al. | Peptide therapeutics in the management of metastatic cancers | |
| CN110461861B (zh) | 人参肽和人参肽类似肽的制备和利用 | |
| IL171204A (en) | Compounds and pharmaceutical compositions containing them and use thereof for the preparation of medicaments | |
| TW202306965A (zh) | Ｐｓｄ－９５抑制劑及其用途 | |
| HU177134B (en) | Process for preparing angiotensin ii analogues containing alpha-hydroxy-acid in position 1 with angiotensin ii antagonist activity | |
| WO2019204402A1 (en) | Compositions and methods for treatment of cancer | |
| JPH06306098A (ja) | 新規なアンジオペプチンシクロペプチド化合物、それらの調製法およびそれらを含む医薬組成物 | |
| JPWO2022101633A5 (enExample) | ||
| TWI234460B (en) | Cyclic pentad-peptide and its preparing method | |
| NZ772052B2 (en) | Bicyclic peptide ligands specific for nectin-4 |